期刊文献+

碱性成纤维细胞生长因子对大鼠动脉血栓形成的影响 被引量:8

EFFECT OF BASIC FIBROBLAST GROWTH FACTOR ON RAT THROMBOSIS OF ARTERY
下载PDF
导出
摘要 目的 :探讨碱性成纤维细胞生长因子 (basic fibroblast growth factor,b FGF)对大鼠颈总动脉血栓形成的影响。方法 :Wistar大鼠 5 0只 ,随机分成生理盐水组、肝素组、b FGF组 (又分 b FGF1 组、b FGF2 组、b FGF3组 ) ,每组 10只。于大鼠的股静脉分别注射生理盐水 (10 m l/kg)、肝素钠 (12 0 0 U /kg)以及 b FGF大、中、小剂量组分别为 80 0 0 0、4 0 0 0 0、1U /kg,给药后 5min,于动脉内插管下方进行电激 ,直至血压曲线的消失 ,记录电激开始至压力曲线消失的时间 ,即血栓堵塞时间。结果 :肝素组和 b FGF组与生理盐水组比较 ,平均堵塞时间延长 (P <0 .0 1) ;肝素组与各 b FGF组之间比较 ,肝素的平均堵塞时间明显较长 (P <0 .0 1)。结论 :b FGF可以延长大鼠动脉血栓形成的时间 ,并呈现一定的量效关系。 Objective:To explore influence of basic fibroblast growth factor(bFGF) on thrombosis in rat common carotid .Methods:50 wistar rats were divided randomly into saline, heparin sodium and (1 200 U/kg)and bFGF groups, doses of bFGF 1, bFGF 2 and bFGF 3 were 80 000、40 000、1 U/kg. respectively (n=10).At 5 min after the drugs were given by femoral veins, electric stimulation below inside-putting tubes of artery was carried out, and recorded the time between starting of electric stimulation and the disappearance of blood pressure curve (namely the blood clot occluding time, BCOT).Result:Compared with Saline group, BCOT heparin and bFGF groups were extended (P<0.01).And BCOT of the heparin group was the longest(P<0.01). Conclusion:bFGF can prolong the time of rat thrombosis of artery with dose-dependent manner.
出处 《广西医科大学学报》 CAS 2004年第5期671-673,共3页 Journal of Guangxi Medical University
关键词 碱性成纤维细胞生长因子 血栓形成 颈总动脉 大鼠 basic fibroblast growth factor (bFGF) thrombosis common carotid rat
  • 相关文献

参考文献11

二级参考文献20

  • 1吕辰.依诺肝素治疗冠状动脉疾病的临床潜力[J].Foreign Medical Sciences Section on Pharmacy,1999,26(4):210-210.
  • 2范亚明 张颖 王绿亚 等.水蛭和水蛭素对实验性动脉粥样硬化的影响及其机理研究.中国动脉硬化杂志,1995,3(2):157-157.
  • 3Stubbs MT, Bode W. A player of many parts: the spotlight falls on thrombin' s structure. Thromb Res, 1993, 69:1-58.
  • 4Weitz JI, Buller HR. Direct thrombin inhibitors in acute coronary syndromes:present and future. Circulation, 2002, 105 (8): 1 004-011.
  • 5Organisation to Access Strategies for Ischaemic Syndromes (OASIS-2) Invesligators. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction,refractory angina,and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: A randomised trial. Lancet, 1999, 353:429-438.
  • 6Antman EM. Hirudin in acute myocardial infarction: safety report from the thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9A trial.Circulation, 1994, 90:1 624-642.
  • 7Neuhaus KL, von Essen R, Tebbe U, Jessel A, Heinrichs H, Maurer W, et al. Safety observation from the pilot phrase of the randomized r-Hirudin for improvement of thrombolysis (HIT- Ⅲ)study:a study of the Arbeitsgemeinschaft Leitender Kardiologscher Krankenhausarzte. Circulation, 1994, 90: 1 638-642.
  • 8The Global Use of Strategies to Open Occluded Arteries (GUSTO) Ⅱb Investigators. A comparison of recombinant hirodin with heparin for the treatment of acute coronary syndromes. N Engl J Med, 1996, 335:775-782.
  • 9Antman EM. Hirudin in acute myocagdial infarction. Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial. Circulation, 1996, 94:911-921.
  • 10Seruys PW, Hemman JP, Simon R, Rutsch W, Bode C, Lamman GJ, et al. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helivetica investigator. N Engl J Med, 1995, 333:757-763.

共引文献62

同被引文献111

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部